Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of asiaticoside in treating bone metabolic abnormality

A technology of bone metabolism abnormality and asiaticoside, which is applied in the application field of asiaticoside in the treatment of bone metabolism abnormality, and achieves the effect of low dose

Active Publication Date: 2018-06-15
THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU UNIV OF CHINESE MEDICINE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But there is no application of asiaticoside in the treatment of bone metabolism disorders

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of asiaticoside in treating bone metabolic abnormality
  • Application of asiaticoside in treating bone metabolic abnormality
  • Application of asiaticoside in treating bone metabolic abnormality

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0018] 1. Ophthalmoxanthin inhibits RANKL-induced osteoclastogenesis

[0019] The structure and properties of asiaticoside such as figure 1 As shown in A.

[0020] For osteoclast culture, freshly isolated bone marrow macrophages (BMM) were isolated from the bones of C57BL / 6 mice, and the cells were flushed from the marrow cavity of the femur and tibia in a-MEM containing M-CSF. Convert the original BMM to 10 3 cells / well were inoculated into a 96-well plate with a-MEM and M-CSF (25ng / mL), and kept at 37°C in 5% CO 2 overnight. BMMs were stimulated with BSAKL (50 ng / mL) and different concentrations of asiaticoside (0.5, 1, 2.5, 5, 10, 20 μmol) every 2 days until osteoclasts formed. Fix with 4% paraformaldehyde in phosphate buffered saline (PBS) for 10 min at room temperature and wash 4 times with PBS. TRAcP activity was detected using the number of TRAcP-positive multinucleated cells. TRAcP-positive multinucleated cells with three or more nuclei were scored as osteoclast-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses asiaticoside, and a function of a pharmaceutically acceptable derivative thereof in bone metabolic abnormality. The asiaticoside has an adjustment function on simultaneously inhibiting osteoclast formation under the situation of bone metabolic abnormality, is low in effective dosage, and has a better effect on adjusting bone metabolic abnormality. The invention defines an intervention way of an asiaticoside related drug. The invention clarifies that a molecular mechanism in a bone microenvironment and a potential pharmacology intervention way are crucial to identifyinga novel treatment compound.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to the application of asiaticoside in the treatment of abnormal bone metabolism. Background technique [0002] Abnormal bone metabolism (Osteoporosis) is a dynamic pathological condition caused by an imbalance between osteoblast bone formation and osteoclast bone resorption. Maintaining the link between osteoclasts and osteoblasts is critical for maintaining bone mass. Once osteoclast-induced bone resorption exceeds osteoblast-induced bone formation, it will progress to osteoporosis. Osteoporosis is primarily characterized by decreased bone mineral and structural disturbances in the skeletal system. Osteoclast and osteoblast differentiation and formation are regulated by several signaling pathways. For the osteoclast system, the receptor activator of NF-κB ligand (RANKL) is a member of the tumor necrosis factor family (TNF) mainly expressed by chondrocytes and osteocytes. RANKL is imp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7024A61P19/08
CPCA61K31/7024
Inventor 洪郭驹魏秋实韩晓蕊徐家科何伟陈镇秋
Owner THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com